Click here to download the product insert for this formulation.
Classification | Injectable |
---|---|
Sub-classification | Intraocular injections |
Strength (Concentration) common dose* | 1.5/1% |
Size (Volume) | 1mL |
Click here to download the product insert for this formulation.
Classification | Injectable |
---|---|
Sub-classification | Intraocular injections |
Strength (Concentration) common dose* | 1.5/1% |
Size (Volume) | 1mL |
*For professional use only. ImprimisRx® Pharmacy specializes in customizing medications to meet unique patient and practitioner needs. ImprimisRx® dispenses only to individually identified patients with valid prescriptions. No compounded medication is reviewed by the FDA for safety or efficacy. ImprimisRx® does not compound copies of commercially available products. References available upon request.
Potential Ingredient Risks
Storage: Store at Room Temperature, 20°C to 25°C (68°F to 77°F)
Auxiliary Labeling: Store upright in original bottle. For professional use only.
Phenylephrine
Possible Indications: Mydriasis, Posterior Synechiae, Uveitis with Posterior Synechiae
Possible Adverse Effects: Increased Intraocular pressure, Hypertension.
Potential Contraindications/Precautions: Lactation, Pregnancy.
Lidocaine HCl
Possible Indications: Ocular Anesthesia
Possible Adverse Effects: Conjunctival Hyperemia, Corneal Epithelial Changes, Headache
Potential Contraindications/Precautions: Infants, Lactation, Pregnancy